Canaccord Genuity Maintains Buy on Compass Pathways, Raises Price Target to $20
Benzinga Newsdesk 4 months ago
NewsPrice TargetAnalyst Ratings
Canaccord Genuity analyst Sumant Kulkarni maintains Compass Pathways (NASDAQ:CMPS) with a Buy and raises the price target from $18 to $20.
Canaccord Genuity analyst Sumant Kulkarni maintains Compass Pathways (NASDAQ:CMPS) with a Buy and raises the price target from $18 to $20.